Placeholder

Alizapride

CAS No:
59338-93-1 Category:
  • # LGM Pharma is a Alizapride CAS# 59338-93-1 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Alizapride
  • CAS #: 59338-93-1
  • Mode of Action:

    The anti-emetic action of Alizapride is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ) in the central nervous system (CNS)ãthis action prevents nausea and vomiting triggered by most stimuli. Structurally similar to metoclopramide and, therefore, shares similar other atributres related to emesis and prokinetics.

  • Pharmacodynamics:

    Alizapride is a dopamine antagonist.

  • IUPAC: 6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1, 2, 3-benzotriazole-5-carboxamide
  • ATC: A03FA05
  • PubChem: 43008
  • DrugBank: DB01425
  • Formula: C21H19N3O3S
  • Molecular Mass: 315.3702
  • Synonyms: Alizaprida [inn-spanish] Alizapridum [inn-latin]
  • SMILES: COC1=CC2=NNN=C2C=C1C(=O)NCC1CCCN1CC=C
  • InChl: KSEYRUGYKHXGFW-UHFFFAOYSA-N
  • General Reference:

    1. Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements